
Pro Medicus signs $128M NYC Health deal
Key points
- Pro Medicus signed a 10-year, $128 million contract with NYC Health + Hospitals through its U.S. subsidiary, Visage Imaging.
- Shares in Pro Medicus traded unchanged at $192.55.
- The company will deploy its cloud-based Visage 7 imaging platform across the health system to replace legacy archives.
Pro Medicus (ASX:PME) announced that its U.S. subsidiary signed a 10-year, $128 million contract with NYC Health + Hospitals.
This agreement adds to a string of recent U.S. hospital deals, following a $43 million contract with Virtual Health and a $24 million deal with Billings Clinic in October.
The transaction-based agreement covers the full Visage 7 software suite, with system rollout targeted for late in the third quarter of 2027.
The company stated that the contract includes migrating legacy imaging archives to its Visage 7 Open Archive and integrating image distribution into the hospital system's electronic health record.
Following the announcement, the Pro Medicus share price was unchanged at $192.55.
Pro Medicus develops medical imaging software and relies on multi-year, cloud-based contracts in North America, where it generated 90% of its fiscal 2026 revenue.
Over recent months, the company also secured a $25 million deal with Valley Health and a $23 million contract with St Luke's Health System and reported a 22.9% rise in full-year revenue to $261.7 million.
Frequently asked questions
More from Australia
Turners Automotive Group posts NZ$31.5M profit in H1
Growthpoint Properties Australia acquires Cammeray Square for $54M
Productivity Commission proposes cutting business reporting rules
Aussie government to introduce super advice laws next week
Argenica’s US stroke trial stalls as FDA demands rat brain study
Echo IQ shares sink 42% as FDA upholds rejection
